The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

Home | Sobre nós | Comités

Comités

Descubra os 5 Comités ERA

Regras Gerais para Comitês da ERA